HIPEC Specialist in Ahmedabad – CRS & HIPEC for Ovarian Cancer

The short answer: For ovarian cancer (andashay ka cancer, अंडाशय का कैंसर), a HIPEC specialist should be a gynaecological oncologist experienced in major cytoreductive surgery, working with a hospital team that has intensive care. HIPEC (heated chemotherapy, sometimes called garam chemo) suits only selected women, mainly with stage 3 (sometimes stage 4) cancer, when all visible tumour can be removed and they are fit for an operation that usually takes 8–14 hours. It is not a guaranteed cure. In Ahmedabad, Dr. Nishtha Tripathi Patel sees patients at Sterling Hospitals, KD Hospital and Welcare Speciality Hospital, and performs HIPEC at Sterling Hospitals and KD Hospital.

If you have been advised cytoreductive surgery (CRS), heated chemotherapy or HIPEC for ovarian cancer, the first question is whether this treatment fits your exact situation. A HIPEC specialist should be able to assess operability, explain whether complete tumour removal is realistic, distinguish established evidence from uncertain uses, coordinate a multidisciplinary team and discuss alternatives without pressuring you into a major operation.

Dr Nishtha Tripathi Patel is an ESGO-certified gynaecological oncologist and ovarian cancer surgeon in Ahmedabad. She evaluates women for cytoreductive surgery (CRS) with HIPEC, including selected women with Stage 3 ovarian or primary peritoneal cancer. A consultation does not mean HIPEC will automatically be recommended.

Which Specialist Performs CRS and HIPEC for Ovarian Cancer?

For ovarian, fallopian-tube or primary peritoneal cancer, the lead surgeon should have dedicated training and regular experience in gynaecological cancer surgery. These operations can involve the ovaries, uterus, peritoneum, diaphragm, bowel, spleen or other abdominal structures. The ability to plan and safely remove visible disease matters more than simply having access to a HIPEC machine.

A gynaecological oncologist specialises in cancers of the female reproductive system and in complex pelvic and abdominal cancer surgery. Depending on the pattern of spread, the operation may also require support from surgical oncology, gastrointestinal surgery, anaesthesia, critical care, pathology, radiology and medical oncology.

HIPEC should therefore be delivered through a hospital team with experience in major cytoreductive surgery, chemotherapy handling, intensive postoperative monitoring and management of complications.

How Do I Choose a HIPEC Specialist in Ahmedabad?

There is no reliable medical league table that identifies one universal “best HIPEC doctor.” The right specialist is the person and team best suited to your cancer type, spread, previous treatment and general health. When comparing surgeons, ask for evidence you can verify.

Be cautious if a consultation promises a cure, gives a survival percentage before reviewing your reports, recommends HIPEC for every Stage 3 case, or describes heated chemotherapy as a replacement for complete surgery and systemic treatment.

Why Consult Dr Nishtha for CRS and HIPEC?

Dr Nishtha Tripathi Patel is a gynaecological oncologist whose practice focuses on cancers of the ovary, uterus, cervix, vulva and vagina. Her qualifications include MBBS, DGO and DNB training in gynaecological oncology, followed by specialist fellowship experience. She is certified by the European Society of Gynaecological Oncology (ESGO).

For a possible HIPEC case, she reviews the cancer diagnosis, disease distribution, earlier chemotherapy response, operative fitness and likelihood of safe cytoreduction. She coordinates with medical oncology, radiology, pathology, anaesthesia and other surgical specialties where needed. Consultations are available in Ahmedabad through Sterling Hospitals, KD Hospital and Welcare Speciality Hospital. Cytoreductive surgery with HIPEC is done at Sterling Hospitals or KD Hospital, not at Welcare; the hospital for an operation depends on the facilities needed and the agreed plan.

The purpose of the visit is to reach a defensible treatment decision. Some women will be suitable for CRS with HIPEC. Others may be advised chemotherapy first, cytoreductive surgery without HIPEC, further imaging, biopsy confirmation, a different systemic treatment or supportive care.

Is HIPEC Suitable for My Ovarian Cancer?

HIPEC is not recommended solely because a report says Stage 3 or Stage 3C. Selection depends on when the operation is being performed, where the cancer has spread, response to chemotherapy, whether visible disease can be removed, organ function and the risks of a prolonged operation.

The strongest randomised evidence in ovarian cancer supports considering HIPEC during interval cytoreductive surgery for selected women with newly diagnosed Stage 3 epithelial ovarian cancer who first received chemotherapy and are fit for major surgery. In that trial (OVHIPEC-1, van Driel and colleagues, New England Journal of Medicine, 2018), interval surgery took place after 3 cycles of chemotherapy, and women who also had HIPEC lived longer on average: median overall survival 45.7 months, compared with 33.9 months without HIPEC. Evidence for adding HIPEC during upfront primary surgery is less consistent. Evidence in recurrent ovarian cancer is mixed, so recurrence alone is not enough reason to recommend it.

Factors commonly reviewed include:

• confirmed ovarian, fallopian-tube or primary peritoneal cancer type;
• CT, MRI or PET-CT findings and disease outside the abdomen;
• response to neoadjuvant chemotherapy, if it was given;
• whether complete or near-complete cytoreduction appears achievable;
• heart, lung, kidney, liver and nutritional fitness;
• previous abdominal operations and complications;
• the expected need for bowel, diaphragm, spleen or other organ surgery; and
• the patient’s priorities after a balanced discussion of benefit and additional risk.

The final decision may change during surgery if the disease pattern is different from the scans or safe cytoreduction cannot be achieved.

What Is the Difference Between CRS and HIPEC?

Cytoreductive surgery (CRS) is the operation that removes visible cancer from the abdomen and pelvis. Patients may call it debulking surgery, ovarian cancer removal surgery or cancer-cleaning surgery. It is a central part of treatment for advanced ovarian cancer; see our guide to ovarian cancer diagnosis and treatment.

HIPEC stands for hyperthermic intraperitoneal chemotherapy. After cytoreduction, heated chemotherapy is circulated inside the abdominal cavity during the same operation to target microscopic cancer cells. Patients may describe it as heated chemo, hot chemotherapy, abdomen-wash chemotherapy, stomach-wash chemotherapy or garam chemo.

CRS and HIPEC are related but not interchangeable. CRS can be performed without HIPEC. HIPEC for ovarian cancer is generally considered only as an addition to appropriately selected cytoreductive surgery; it is not a substitute for removing visible disease. Read the separate patient guide to how HIPEC treatment works for procedural details.

What Happens at a HIPEC Consultation?

The specialist first confirms the clinical question: is this a new diagnosis, an interval operation after chemotherapy, residual disease after earlier treatment or a recurrence? The scan is reviewed for the location and likely operability of disease, not merely the written stage.

The consultation should then address:

1. Diagnosis: pathology type, grade and molecular information where relevant.
2. Current disease map: abdomen, pelvis, lymph nodes, chest and any sites outside the usual surgical field.
3. Previous treatment: chemotherapy medicines, number of cycles, response, surgery and complications.
4. Operability: whether complete cytoreduction is realistic and which organs might require treatment.
5. HIPEC evidence: whether your treatment setting resembles the patients studied in clinical trials.
6. Safety: anaesthetic fitness, nutrition, kidney function and recovery support.
7. Alternatives: what can reasonably be done if CRS or HIPEC is unsuitable.

A decision may require updated imaging, pathology review, blood tests, anaesthetic assessment or discussion at a multidisciplinary meeting.

What Reports Should I Bring for a CRS and HIPEC Opinion?

• biopsy, operation and final histopathology reports;
• the actual CT, MRI or PET-CT images on disc or an online link, plus written reports;
• chemotherapy records showing drug names, dates and number of cycles;
• CA-125 and other relevant tumour-marker trends;
• previous operation notes and discharge summaries;
• recent blood counts, kidney and liver tests;
• a list of medicines, allergies and major health conditions; and
• details of any infection, blood clot, heart, lung or kidney problem during treatment.

Images are often more useful than a written scan conclusion alone because surgical planning depends on the precise distribution of disease.

What Should I Ask My HIPEC Surgeon?

• Do I match the group in which HIPEC has shown benefit?
• Is this primary, interval or secondary cytoreductive surgery?
• What makes you believe complete tumour removal is achievable?
• Which organs might need partial or complete removal?
• Could I need a temporary or permanent stoma?
• Which chemotherapy medicine, temperature and duration are planned for HIPEC?
• What additional benefit might HIPEC offer over surgery and chemotherapy alone in my setting?
• What additional complications does it introduce?
• Who will participate in the operation and postoperative care?
• When would you decide not to deliver HIPEC during the operation?
• When would intravenous chemotherapy restart after recovery?
• Should I obtain another opinion before committing to surgery?

What Are the Risks and Recovery After CRS and HIPEC?

Recovery depends more on the extent of cytoreductive surgery than on the label “HIPEC.” Possible problems include bleeding, infection, blood clots, chest infection, slow bowel recovery, leakage after bowel surgery, kidney injury, changes in blood counts and the need for intensive monitoring. A larger operation can mean a longer hospital stay and a slower return to eating, walking and independent activity.

As a general guide, the operation usually takes 8–14 hours, and most women stay in hospital about 10–14 days, including 3–5 days in the ICU (intensive care). Gentle daily activity usually returns in about 4–6 weeks, and full recovery takes about 3–4 months. Your own timeline depends on the extent of surgery and any complications. Our step-by-step guide explains preparation and recovery around HIPEC.

The 2025 meta-analysis of randomised trials found that HIPEC increased operating time, hospital stay and serious adverse events overall. This is why the possible survival benefit must be weighed against individual surgical risk. Ask for an expected range rather than a guaranteed discharge or recovery date.

After discharge, contact the team for fever, worsening abdominal pain, persistent vomiting, inability to drink, increasing wound redness or discharge, breathlessness, leg swelling, very low urine output or a sudden decline in strength.

What Is the Cost of HIPEC Treatment in Ahmedabad?

There is no responsible single price before the operation is planned. The total depends on the hospital, operation length, organs involved, HIPEC drug and equipment, surgeon and anaesthesia teams, intensive-care requirement, room category, pathology, blood products, complications and length of stay. Indicative ranges (not a quote) are given in the cost section of our HIPEC page.

Ask for a written estimate that separates expected hospital and professional charges and explains what is excluded. Also ask whether cashless insurance authorisation is possible and which documents the insurer requires. A lower package price is not automatically better if it assumes a smaller operation than the cancer requires or excludes likely postoperative care.

Frequently Asked Questions

Who is the best doctor for HIPEC in Ahmedabad?

No independent ranking can identify one “best” doctor for every patient. Choose a cancer-specific surgeon with appropriate gynaecological oncology training, cytoreductive-surgery experience, multidisciplinary hospital support and a willingness to explain when HIPEC should not be used.

Do I need a surgical oncologist for HIPEC?

You need a surgeon trained for the cancer and operation involved. For ovarian cancer, a gynaecological oncologist should lead or be centrally involved, with other surgical specialists added when the disease pattern requires them.

Is HIPEC recommended for every Stage 3 ovarian cancer?

No. Stage alone does not establish eligibility. Timing of surgery, chemotherapy response, disease distribution, ability to remove visible tumour and fitness for major surgery all matter.

Is CRS always required with HIPEC?

For ovarian-cancer treatment, HIPEC is normally considered in connection with cytoreductive surgery. Heated chemotherapy does not replace the removal of visible disease.

Should I get a second opinion before CRS and HIPEC?

A second opinion is reasonable before a major, irreversible operation, especially when operability, organ removal or the value of HIPEC in your treatment setting is uncertain. You can request a gynaecological cancer second opinion with your scans and reports.

Can recurrent ovarian cancer be treated with CRS and HIPEC?

Selected recurrent cases may be considered, but the survival evidence for adding HIPEC in recurrence is mixed. The first decision is whether secondary cytoreductive surgery itself is appropriate and complete tumour removal appears achievable.

How long is recovery after CRS and HIPEC?

It varies with the extent of surgery and any complications. Most women stay in hospital about 10–14 days, including 3–5 days in the ICU; gentle daily activity usually returns in about 4–6 weeks, and full recovery takes about 3–4 months. The surgeon can give a more useful estimate after reviewing the planned organ procedures.

Where does Dr. Nishtha perform HIPEC in Ahmedabad?

At Sterling Hospitals (Sindhubhavan Road) and KD Hospital. You can have your first consultation at any of her three Ahmedabad hospitals, including Welcare Speciality Hospital, but HIPEC surgery is not done at Welcare.

Related Information and Medical Sources

For more detail, read about HIPEC treatment, cytoreductive surgery, ovarian cancer treatment and surgery-first versus chemotherapy-first decisions in Stage 3C ovarian cancer.

• 2025 systematic review and meta-analysis of randomised HIPEC trials
• Randomised trial of HIPEC during interval surgery for Stage 3 ovarian cancer
• US National Cancer Institute: ovarian epithelial cancer treatment